Literature DB >> 9294783

Progress against endemic goiter in Croatia--mandatory salt iodination increased after 40 years of implementation.

Z Kusić, S Lechpammer, F Delange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9294783     DOI： 10.1007/BF03350316

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

Review 1.  Cancer consequences of the Chernobyl accident in Europe outside the former USSR: a review.

Authors:  D Sali; E Cardis; L Sztanyik; A Auvinen; A Bairakova; N Dontas; B Grosche; A Kerekes; Z Kusic; C Kusoglu; S Lechpammer; M Lyra; J Michaelis; E Petridou; Z Szybinski; S Tominaga; R Tulbure; A Turnbull; Z Valerianova
Journal:  Int J Cancer       Date:  1996-07-29       Impact factor: 7.396

2.  Current status of endemic goiter in Croatia: the results of a nationwide study (1995).

Authors:  Z Kusić; N Daković; A Kaić-Rak; I Karner; S Lechpammer; E Mesaros-Simuncić; I Petrović; S Roncević; J Smoje; A Stanicić; I Valent; F Delange
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

3.  [Endemic goiter in Croatia].

Authors:  Z Kusić; S Lechpammer; N Daković; A Kaić-Rak; I Karner; E Mesaros-Simuncić; I Petrović; S Roncević; J Smoje; A Stanicic; F Delange
Journal:  Lijec Vjesn       Date:  1996 May-Jun

4.  Endemic goiter and iodine deficiency in Yugoslavia.

Authors:  Z Kusić
Journal:  J Endocrinol Invest       Date:  1989-06       Impact factor: 4.256
  4 in total
  2 in total

1.  Croatia has reached iodine sufficiency.

Authors:  Z Kusić; S A Novosel; N Dabelić; M Punda; S Roncević; Z Labar; Lj Lukinac; D Nöthig-Hus; A Stanicić; A Kaić-Rak; E Mesaros-Kanjski; I Karner; J Smoje; N Milanović; M Katalenić; V Juresa; V Sarnavka
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

2.  First beneficial results of the implementation of Croatian new law on salt iodination.

Authors:  Z Kusić; S Lechpammer; L Lukinac; I Petrović; D Nöthig-Hus
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.